EFPIA workshop: the 2001 review of European Union pharmaceutical legislation

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.15, Iss.3, 2001-06, pp. : 145-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret Woods Kent

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Pharmaceutical biotechnology products approved within the European Union

By Walsh G.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965–2007: case Finland

International Journal Of Health Planning And Management, Vol. 30, Iss. 3, 2015-07 ,pp. : 260-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Single European Currency and Monetary Union: Macroeconomic Implications for Pharmaceutical Spending

By Kanavos P.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite

The Pharmaceutical Group of the European Union (PGEU) has published guidelines

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite